# An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

> **NCT00726388** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1050 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** DIC075V (intravenous diclofenac sodium)

## Key facts

- **NCT ID:** NCT00726388
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-15
- **Primary completion:** 2009-05-08
- **Final completion:** 2009-05-08
- **Target enrollment:** 1050 (ACTUAL)
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726388, "An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00726388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*